Activation of Platelet Factor 3 by Adenosine 5’Diphosphate

Summary

Adenosine 5’diphosphate activates platelet factor 3 of intact platelets in citrated, heparinized or native plasma. PF-3 activation is dependent on the dose of ADP, and is achieved with sufficient speed to suggest that it can play a physiological role in blood coagulation. ADP-induced platelet aggregation is inhibited by AMP (but not ATP), 2-chloro adenosine, phosphoenol pyruvate and phosphoenol pyruvate kinase, and diguanidinodiphenyl sulfone. Other agents which aggregate platelets induce PF-3 activation; the effects of norepinephrine, serotonin, low doses of trypsin and thrombin, and endotoxin in the human can be inhibited by AMP but the action of latex or celite particles cannot be fully inhibited by AMP. PF-3 activation requires higher ADP concentrations than does ADP-induced platelet aggregation. Guanidinosuccinic acid blocks the action of ADP on PF-3 activation without affecting its action on aggregation. ADP-induced PF-3 activation is unrelated to activation of factors XII and XI. Though PF-3 activation usually occurs in parallel with platelet aggregation the two actions of ADP of platelets may occur independently.

• References

• 1 Fantl P, Ward H.A. The thromboplastin component of intact blood platelets is present in washed form. Aust. J. exp. Biol. 1958; 36: 499
• 2 Des Prez R.M, Horowitz H.I, Hook E.W. Effects of bacterial endotoxin on rabbit platelets I. Platelet aggregation and release of platelet factors in vitro. J. exp. Med. 1961; 114: 857
• 3 Horowitz H.I, Spaet T.H. Generation of coagulation product I and its interaction with platelets and phospholipids. J. appl. Physiol 1961; 16: 112
• 4 Horowitz H.I, Papayoanou M.F. Release of non-sedimentable platelet factor 3 during coagulation. J. Lab. clin. Med. 1967; 69: 1003
• 5 Mustard J.F, Hegardt B, Rowsell H.C, MacMillan R.L. Effect of adenosine nucleotides on platelet aggregation and clotting time. J. Lab. clin. Med. 1964; 64: 548
• 6 Castaldi P.A, Larrieu M.J, Caen J. Availability of platelet factor 3 and activation of factor XII in thrombasthenia.. Nature (Lond.) 1965; 207: 422
• 7 Hardisty R, Hutton R. Platelet aggregation and the availability of paletelet factor 3. Brit. J. Haemat. 1966; 12: 764
• 8 Horowitz H.I. Platelet factor 3 in platelet release reactions. First International Symposium on Blood Platelets. Buenos Aires 1965
• 9 Hovig T. Release of a platelet-aggregating substance (adenosine diphosphate) from rabbit blood platelets induced by saline “extract” of tendons. Thrombos. Diathes. haemorrh. (Stuttg.) 1963; 9: 264
• 10 Spaet T.H, Zucker M.B. Mechanism of platelet plug formation and role of adenosine diphosphate. Amer. J. Physiol. 1964; 206: 1276
• 11 Marcus A.J, Zucker M.B. The Physiology of Blood Platelets, Grune & Stratton. New York 1965
• 12 Spaet T.H, Erickson R.B, Spielvogel A.R. The Hemostatic Sequence. 2nd Henry Ford Hospital International Symposium on Blood Platelets.. Johnson S. A. Little Brown & Co.; Boston: ed (In press.).
• 13 Mertz E.T, Owen C.A. Imidazole buffer: its use in Blood clotting studies. Proc. Soc. exp. Biol. (N.Y.) 1940; 43: 204
• 14 Haslam R.J. Role of ADP in aggregation of human blood platelets by thrombin and fatty acids. Nature (Lond.) 1964; 202: 765
• 15 Horowitz H.I, Fujimoto M.M. Association of factors XI and XII with blood platelets. Proc. Soc. exp. Biol. (N.Y.) 1965; 119: 487
• 16 Brown G.V.R, Gross M.J. Inhibition of the aggregation of blood platelets by substances related to adenosine diphosphate. J. Physiol. 1963; 166: 29
• 17 O’Brien J.R. A comparison of platelet aggregation produced by seven compounds and a comparison of their inhibitors. J. clin. Path. 1964; 17: 275
• 18 Born G.V.R. Strong inhibition by 2-chloro adenosine of the aggregation of blood platelets by adenosine diphosphate. Nature (Lond.) 1964; 202: 95
• 19 Jerushalmy Z, Skoza L, Zucker M.B, Grant R. Inhibition by guanidino compounds of platelet aggregation induced by adenosine diphosphate. Biochem. Pharmacol. 1966; 15: 1791
• 20 Haslam R.J. Role of adenosine diphosphate in the aggregation of human blood platelets.. Nature (Lond.) 1964; 202: 765
• 21 Horowitz H.I, Cohen B.D, Martinez P, Papayoanou M.F. Defective ADP-induced platelet factor 3 activation in uremia. Blood 1967; 30: 331
• 22 Horowitz H.I, Marcus A.J. The development of platelet factor 3 activity by latex particles. – An interaction with plasma. Blood 23 2 1964: 178 P
• 23 Horowitz H.I, Des Prez R.M, Hook E.W. Effects of bacterial endotoxins on rabbit platelets II. Enhancement of platelet factor 3 activity in vitro and in vivo. J. exp. Med. 1962; 116: 619
• 24 Ream V.J, Deykin D, Gurewich V, Wessler S. The aggregation of human platelets by bacterial endotoxin. J. Lab. clin. Med. 1965; 66: 245
• 25 Hardisty R.M, Hutton R.A. The kaolin clotting time of platelet-rich plasma: A test of platelet factor 3 availability. Brit. J. Haemat. 1965; 11: 258
• 26 Spaet T.H, Cintron J. Studies on platelet factor 3 availability. Brit. J. Haemat. 1965; 11: 269
• 27 Horowitz H.I. Platelet factor 3 activation by celite powder. Thrombos. Diathes. haemorrh. (Stuttg.) (Suppl.) 1965; 17: 113
• 28 Bonas J.E, Cohen B.D, Natelson S. Separation and estimation of certain guanidino compounds. Microchem. J. 1963; 7: 1
• 29 Natelson S.I, Stein I.M, Bonas J.E. Improvements in the methods of separation and identification of guanidino organic acids by column chromatography. Isolation and identification of guanidino-succinic acid from human urine. Microchem. J. 1964; 8: 371
• 30 Cohen B.D, Stein I.M, Bonas J.E. Guanidinosuccinic aciduria: an alternate route of ammonia detoxification in uremia. Ann. Int. Med. 1966; 64: 1171
• 31 Mustard J.F, Glynn M.F, Nishigawa E.F, Packham M.A. Platelet surface interactions: Relationship to thrombosis and hemostasis. Fed. Proc. 1967; 26: 106
• 32 Spielvogel A.R. An ultrastructural study of the mechanisms of platelet-endotoxin interactions. Blood 1966; 28: 985